Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (1-10 of 616) with videos related to

Pageof 62
Sort By:
Journal of Gastroenterology and Hepatology|January 27, 2017
Hepatitis C treatment from "response-guided" to "resource-guided" therapy in the transition era from interferon-containing to interferon-free regimensMing-Lung Yu
Journal of Hepatology|January 23, 2016
Statin use and the risk of cirrhosis development in patients with hepatitis C virus infectionMing-Lung Yu
Hepatology (Baltimore, Md.)|April 12, 2011
The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis CMing-Lung Yu
The Lancet. Infectious Diseases|April 28, 2017
Short duration of direct-acting antivirals for acute HCV infectionMing-Lung Yu
Gastroenterology|August 8, 2017
Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis CMing-Lung Yu
Gastroenterology|October 10, 2017
Association Between Screen-detected Gallstone Disease and Cancer in a Cohort StudyMing-Lung Yu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 6, 2018
Reply to "The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world"Ming-Lung Yu
Journal of Gastroenterology and Hepatology|April 2, 2009
Treatment of chronic hepatitis C in Asia: when East meets WestMing-Lung Yu, Wan-Long Chuang
Clinical Liver Disease|July 18, 2019
New treatments for HCV: Perspective from AsiaMing-Lung Yu, Wan-Long Chuang
Clinical and Molecular Hepatology|December 3, 2024
Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on "Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial"Chih-Wen Wang, Ming-Lung Yu
Pageof 62

Showing results (1-10 of 616) with videos related to

Sort By:
Pageof 62
Journal of Gastroenterology and Hepatology|January 27, 2017
Hepatitis C treatment from "response-guided" to "resource-guided" therapy in the transition era from interferon-containing to interferon-free regimensMing-Lung Yu
Journal of Hepatology|January 23, 2016
Statin use and the risk of cirrhosis development in patients with hepatitis C virus infectionMing-Lung Yu
Hepatology (Baltimore, Md.)|April 12, 2011
The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis CMing-Lung Yu
The Lancet. Infectious Diseases|April 28, 2017
Short duration of direct-acting antivirals for acute HCV infectionMing-Lung Yu
Gastroenterology|August 8, 2017
Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis CMing-Lung Yu
Gastroenterology|October 10, 2017
Association Between Screen-detected Gallstone Disease and Cancer in a Cohort StudyMing-Lung Yu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 6, 2018
Reply to "The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world"Ming-Lung Yu
Journal of Gastroenterology and Hepatology|April 2, 2009
Treatment of chronic hepatitis C in Asia: when East meets WestMing-Lung Yu, Wan-Long Chuang
Clinical Liver Disease|July 18, 2019
New treatments for HCV: Perspective from AsiaMing-Lung Yu, Wan-Long Chuang
Clinical and Molecular Hepatology|December 3, 2024
Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on "Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial"Chih-Wen Wang, Ming-Lung Yu
Pageof 62